Skip to content
MedsAcross

Molecule

Mebrofenin

Available on request
Presentations
2
Brands
1
Manufacturers
1
Available from stock
0

Mebrofenin is a prescription medicine indicated as a hepatobiliary imaging agent. It is available as powder for injection for intravenous use. MedsAcross supplies Mebrofenin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
Not recorded
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravenous
Dosage forms
Powder for injection
Identifiers
UNII 7PV0B6ED98RxCUI 1311500CAS 78266-06-5DrugBank DB15779Q27268694

Clinical information

From the regulator-approved product information. Each section names its source.

Dosing overview

The suggested intravenous dose range of Technetium Tc 99m Mebrofenin in the average patient (70 kg) is: Nonjaundiced patient: 74-185 MBq (2-5 mCi) Patient with serum bilirubin level greater than 1.5 mg/dL: 111-370 MBq (3-10 mCi) The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. The patient should be in a fasting state, 4 hours is preferable. False positives (non-visualization) may result if the gallbladder has been emptied by ingestion of food. An interval of at least 24 hours should be allowed before repeat examination. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Source: US FDA prescribing information

Warnings and precautions

The theoretical possibility of allergic reactions should be considered in patients who receive multiple doses.

Source: US FDA prescribing information

Side effects

Urticaria and rash have been rarely reported with the use of Technetium Tc 99m Mebrofenin since market introduction. Rare cases of chills and nausea have been reported with related compounds. Infrequently, death has been reported in association with the use of this class of agents.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Mebrofenin, sorted by availability.

MedicineManufacturerRegisterAvailability
Mebrofenin 45 mg/10 mL powder for injectionIntravenousGeneric name—US FDAAvailable on request
Choletec 45 mg powder for injectionIntravenousBracco DiagnosticsUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDANot recorded—
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Mebrofenin available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Mebrofenin and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Mebrofenin have?

The catalogue lists 1 brand names for Mebrofenin, including Choletec.

Does Mebrofenin need cold chain shipping?

No listed presentation of Mebrofenin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Choletec prescribing information (Bracco Diagnostics). U.S. National Library of Medicine, DailyMed. Retrieved 29 November 2025

Request Mebrofenin for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.